NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
NextCure, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$5.67−0.57 (-9.13%)
Close on Oct 19, 2026
- Market cap
- $30.11M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Dividends
NextCure has not reported a dividend
No dividend per share appears in NextCure's annual filings since fiscal 2017.